Parry Nutraceuticals' Indian microalgae facility receives USFDA approval

Capital Market 

Located at Oonaiyur, Pudukottai district, Tamil Nadu

(India) announced that Parry Nutraceuticals (a division of and part of the Murugappa Group) has received the US FDA approval for its India facility for organic microalgae cultivation and processing. The fully organic, 130 acres - 600 TPA facility, located in Oonaiyur, Pudukottai district, Tamil Nadu, has received the Establishment Inspection Report (EIR) from the US-FDA following an inspection of the facility in July 2016.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Parry Nutraceuticals' Indian microalgae facility receives USFDA approval

Located at Oonaiyur, Pudukottai district, Tamil Nadu

Located at Oonaiyur, Pudukottai district, Tamil Nadu

(India) announced that Parry Nutraceuticals (a division of and part of the Murugappa Group) has received the US FDA approval for its India facility for organic microalgae cultivation and processing. The fully organic, 130 acres - 600 TPA facility, located in Oonaiyur, Pudukottai district, Tamil Nadu, has received the Establishment Inspection Report (EIR) from the US-FDA following an inspection of the facility in July 2016.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22